Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Product Features Available in 5mg and 10mg vial options Selective GHSR-1a receptor agonist Lyophilised powder in sterile, sealed vial High purity verified through third-party analytical testing Tamper-evident, batch-labelled packaging Suitable for laboratory and in-vitro research applications Research Applications Ipamorelin is commonly utilised in laboratory environments involving: Growth hormone secretagogue receptor (GHSR-1a) signalling Peptidereceptor interaction studies cAMP/PKA and PLC/IP3/Ca pathway modelling Structureactivity relationship investigations Controlled endocrine and signalling pathway research Molecular biology and receptor pharmacology studies Its selective receptor activity profile has made Ipamorelin a valuable compound within controlled peptide-signalling and receptor pathway investigations
It is entirely possible that the slight rise in optic nerve issues reflects the underlying, advanced vascular damage or high baseline cardiovascular strains already present in patients who require these stronger medications, rather than a direct toxic effect of the drug molecules themselves
For the broader picture of which peptides already have FDA approval, see our FDA Approved Peptides List 2026
As vials arrive as a freeze dried powder they must be reconstituted (turned back into liquid form) before they can be used
